All Stories

  1. Assessing the relationship between body mass index and substance craving among patients with substance use disorders

    Article • Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity, February 2026, Springer Science + Business Media

    Daniel Feaster

  2. Establishing a public health surveillance system for the opioid crisis: The experience of the HEALing Communities Study

    Article • Journal of Substance Use and Addiction Treatment, February 2026, Elsevier

    Daniel Feaster

  3. Do Communities Implementing the Communities That HEAL Intervention Have Significantly Lower Rates of High-Risk Opioid Prescribing and Dispensing?

    Article • AJPM Focus, December 2025, Elsevier

    Daniel Feaster

  4. The effects of psychological functioning on substance use and treatment outcomes among people with HIV

    Article • Scientific Reports, October 2025, Springer Science + Business Media

    Dr. Prof. Lunthita M Duthely, Daniel Feaster

  5. Lower Prepregnancy Cardiovascular Health is Associated With Hypertensive Disorders of Pregnancy: The CARDIA Study

    Article • Hypertension, October 2025, Wolters Kluwer Health

    Daniel Feaster

  6. Latent class and time-to-event analyses of social determinants of health and COVID-19 vaccine uptake among Black women living with HIV

    Article • Vaccine, October 2025, Elsevier

    Daniel Feaster

  7. HIV Treatment Disruption and Viral Suppression Among Venezuelan Immigrants Living with HIV in Miami: A Comparative Analysis

    Article • AIDS and Behavior, September 2025, Springer Science + Business Media

    Daniel Feaster

  8. Effects of the Communities That HEAL intervention on initiation, retention, and linkage to medications for opioid use disorder (MOUD): A cluster randomized wait-list controlled trial

    Article • Drug and Alcohol Dependence, September 2025, Elsevier

    Daniel Feaster

  9. HEALing Communities Study: Data measures for supporting a community-based intervention to reduce opioid overdose deaths

    Article • Drug and Alcohol Dependence, September 2025, Elsevier

    Daniel Feaster

  10. HIV knowledge and reported stigma among South Florida health fair participants

    Article • PLOS One, August 2025, PLOS

    Daniel Feaster

  11. The Practical, Robust Implementation and Sustainability (PRISM)-capabilities model for use of Artificial Intelligence in community-engaged implementation science research

    Article • Implementation Science, August 2025, Springer Science + Business Media

    Daniel Feaster

  12. System dynamics modeling to inform implementation of evidence-based prevention of opioid overdose and fatality: A state-level model from the New York HEALing Communities Study

    Article • International Journal of Drug Policy, August 2025, Elsevier

    Daniel Feaster

  13. Linear growth modeling of religious coping and social support among Black women living with HIV in the context of the COVID-19 pandemic

    Article • AIDS Care, July 2025, Taylor & Francis

    Daniel Feaster

  14. Healthcare provider stigma toward patients with substance use disorders

    Article • Addiction, July 2025, Wiley

    Daniel Feaster

  15. Artificial Intelligence and Stigma in Addiction Research: Insights From the HEALing Communities Study Coalition Meetings

    Article • Journal of Addiction Medicine, June 2025, Wolters Kluwer Health

    Daniel Feaster

  16. The Epidemiology of the Long-Term Care Needs and Unmet Needs of Older Veterans in the United States

    Article • Journal of Clinical Medicine, June 2025, MDPI AG

    Daniel Feaster

  17. The effectiveness of the communities that HEAL intervention on reducing non-fatal opioid overdoses: A prespecified secondary analysis of a waitlist cluster control randomized controlled trial

    Article • International Journal of Drug Policy, June 2025, Elsevier

    Daniel Feaster

  18. Associations Between Racial Residential Segregation and Hypertensive Disorders of Pregnancy among Black women: The Coronary Artery Risk Development in Young Adults Study

    Article • International Journal of Cardiology Cardiovascular Risk and Prevention, June 2025, Elsevier

    Daniel Feaster

  19. Correction to: Project RETAIN: Providing Integrated Care for People with HIV who use Cocaine

    Article • Open Forum Infectious Diseases, April 2025, Oxford University Press (OUP)

    Daniel Feaster

  20. Abstract P1139: Lower Pre-Pregnancy Cardiovascular Health is Associated with Higher Odds of Hypertensive Disorders of Pregnancy: Coronary Artery Risk Development in Young Adults Study (CARDIA)

    Article • Circulation, March 2025, Wolters Kluwer Health

    Daniel Feaster

  21. Project RETAIN: Providing Integrated Care for People With HIV Who Use Cocaine

    Article • Open Forum Infectious Diseases, March 2025, Oxford University Press (OUP)

    Daniel Feaster

  22. Assessing the Relationship between Body Mass Index and Substance Craving Among Patients With Substance Use Disorder

    Article • Drug and Alcohol Dependence, February 2025, Elsevier

    Daniel Feaster

  23. Development of a brief stigma and perceptions questionnaire for pharmacists: An exploratory factor analysis approach in New York state counties enrolled in the healing communities study

    Article • Journal of Substance Use and Addiction Treatment, February 2025, Elsevier

    Daniel Feaster

  24. Development of the Brief Stigma and Perceptions Questionnaire for Pharmacists: A Confirmatory Factor Analysis Approach in New York State Counties Enrolled in the Healing Communities Study

    Article • Drug and Alcohol Dependence, February 2025, Elsevier

    Daniel Feaster

  25. Latino Sexual Minority Men’s Pre-Exposure Prophylaxis Modality Preferences: A Latent Class Analysis

    Article • AIDS Patient Care and STDs, February 2025, SAGE Publications

    Daniel Feaster

  26. Opioid use disorder prevalence in 57 New York counties from 2017 to 2019: A Bayesian evidence synthesis

    Article • Drug and Alcohol Dependence, February 2025, Elsevier

    Daniel Feaster

  27. Implementation Determinants of PrEP and Behavioral Health Treatment Referral among HIV Test Counselors

    Article • AIDS and Behavior, January 2025, Springer Science + Business Media

    Daniel Feaster

  28. Sexual Health Advocacy for Guys (SHAG): a randomized trial of the impact of a text-messaging program on HIV incidence and STI testing among a national sample of sexual minority cisgender adolescent and young adult men

    Article • Trials, January 2025, Springer Science + Business Media

    Daniel Feaster

  29. Effect of the Communities That HEAL Intervention on Overdose Education and Naloxone Distribution: A Cluster-Randomized, Wait-List Controlled Trial

    Article • American Journal of Public Health, January 2025, American Public Health Association

    Daniel Feaster

  30. Willingness to Use Oral and Long-Acting Injectable PrEP in Substance-Using Men who have Sex with Men (SU-MSM) in High HIV Incidence Southern U.S. Cities: A NIDA Clinical Trials Network Study

    Article • AIDS and Behavior, December 2024, Springer Science + Business Media

    Daniel Feaster

  31. A commentary on forging a path for CHANGE: culturally focused HIV training for the next generation in pursuit of equity

    Article • Critical Public Health, December 2024, Taylor & Francis

    Daniel Feaster

  32. Data cleaning and harmonization of clinical trial data: Medication-assisted treatment for opioid use disorder

    Article • PLOS One, November 2024, PLOS

    Daniel Feaster

  33. Communities That HEAL Intervention and Mortality Including Polysubstance Overdose Deaths

    Article • JAMA Network Open, October 2024, American Medical Association (AMA)

    Daniel Feaster

  34. Community-Based Cluster-Randomized Trial to Reduce Opioid Overdose Deaths

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, September 2024, New England Journal of Medicine (NEJM/MMS)

    Daniel Feaster

  35. Testing for Measurement Invariance (MI): Do the Structures of Microaggression, Discrimination, and Resilience Among Black Women Living with HIV Remain the Same Across Time?

    Article • Journal of Racial and Ethnic Health Disparities, August 2024, Springer Science + Business Media

    Daniel Feaster

  36. Buprenorphine Prescribing Characteristics Following Relaxation of X-Waiver Training Requirements

    Article • JAMA Network Open, August 2024, American Medical Association (AMA)

    Daniel Feaster

  37. Psychosocial Factors Linked to Uncontrolled Infection and Mortality among People Living with HIV Who Use Substances: A Latent Class Analysis

    Article • AIDS and Behavior, August 2024, Springer Science + Business Media

    Daniel Feaster

  38. Diabetes Management in Patients With Substance Use Disorder Served in a Network of Federally Qualified Health Centers in Florida: A Retrospective Analysis Using EHR Data

    Article • Drug and Alcohol Dependence, July 2024, Elsevier

    Daniel Feaster

  39. Estimating the potential value of MSM‐focused evidence‐based implementation interventions in three Ending the HIV Epidemic jurisdictions in the United States: a model‐based analysis

    Article • Journal of the International AIDS Society, July 2024, Wiley

    Daniel Feaster

  40. HIGH SUICIDALITY PREDICTS OVERDOSE EVENTS AMONG PEOPLE WITH SUBSTANCE USE DISORDER: A LATENT CLASS ANALYSIS

    Article • Drug and Alcohol Dependence, July 2024, Elsevier

    Daniel Feaster

  41. Latent Class Analysis of Psychosocial Factors Among People Living with HIV who Use Substances

    Article • Drug and Alcohol Dependence, July 2024, Elsevier

    Daniel Feaster

  42. PrEP and PEP Experience and Willingness in People who Use Opioids: A NIDA Clinical Trials Network Study in Southern U.S. Cities Where HIV Incidence Is High

    Article • Drug and Alcohol Dependence, July 2024, Elsevier

    Daniel Feaster

  43. Prep Experience and Willingness in Substance-Using MSM in Higher Incidence Southern U.S. Cities: NIDA Clinical Trials Network Study

    Article • Drug and Alcohol Dependence, July 2024, Elsevier

    Daniel Feaster

  44. Soluble Plasma Proteins of Tumor Necrosis Factor and Immunoglobulin Superfamilies Reveal New Insights into Immune Regulation in People with HIV and Opioid Use Disorder

    Article • Vaccines, May 2024, MDPI AG

    Daniel Feaster

  45. Soluble Plasma Proteins of Tumor Necrosis Factor and Immunoglobulin Superfamilies Reveal New Insights into Immune Regulation in People with HIV and Opioid Use Disorde

    Article • The Journal of Immunology, May 2024, Oxford University Press (OUP)

    Daniel Feaster

  46. Disadvantaged groups have greater spatial access to pharmacies in New York state

    Article • BMC Health Services Research, April 2024, Springer Science + Business Media

    Daniel Feaster

  47. PrEP for people who use opioids: A NIDA clinical trials network survey study in Southern U.S. cities where HIV incidence is high

    Article • Drug and Alcohol Dependence, April 2024, Elsevier

    Daniel Feaster

  48. Project CHARIOT: study protocol for a hybrid type 1 effectiveness-implementation study of comprehensive tele-harm reduction for engagement of people who inject drugs in HIV prevention services

    Article • Addiction Science & Clinical Practice, March 2024, Springer Science + Business Media

    Daniel Feaster

  49. Impact of the Communities That HEAL Intervention on Buprenorphine-Waivered Practitioners and Buprenorphine Prescribing

    Article • JAMA Network Open, February 2024, American Medical Association (AMA)

    Daniel Feaster

  50. Simulating the Simultaneous Impact of Medication for Opioid Use Disorder and Naloxone on Opioid Overdose Death in Eight New York Counties

    Article • Epidemiology, February 2024, Wolters Kluwer Health

    Daniel Feaster

  51. Individual-Level Risk Prediction of Return to Use During Opioid Use Disorder Treatment

    Article • JAMA Psychiatry, January 2024, American Medical Association (AMA)

    Daniel Feaster

  52. Bon Sante (Good Health): Factors Influencing PrEP Use Among Haitians/Haitian Americans

    Article • Journal of Racial and Ethnic Health Disparities, November 2023, Springer Science + Business Media

    Daniel Feaster

  53. Estimating the epidemiological impact of reaching the objectives of the Florida integrated HIV prevention and care plan in Miami-Dade County

    Article • The Lancet Regional Health - Americas, November 2023, Elsevier

    Daniel Feaster

  54. Opioids exacerbate inflammation in people with well-controlled HIV

    Article • Frontiers in Immunology, November 2023, Frontiers

    Daniel Feaster

  55. Telemedicine Buprenorphine Initiation and Retention in Opioid Use Disorder Treatment for Medicaid Enrollees

    Article • JAMA Network Open, October 2023, American Medical Association (AMA)

    Daniel Feaster

  56. Risks of returning to opioid use at treatment entry and early in opioid use disorder treatment: Role of non-opioid substances

    Article • Drug and Alcohol Dependence, October 2023, Elsevier

    Daniel Feaster

  57. Health Care Provider Stigma Toward Patients With Substance Use Disorders: Protocol for a Nationally Representative Survey

    Article • JMIR Research Protocols, September 2023, JMIR Publications Inc.

    Daniel Feaster

  58. Massachusetts Prevalence of Opioid Use Disorder Estimation Revisited: Comparing a Bayesian Approach to Standard Capture–Recapture Methods

    Article • Epidemiology, September 2023, Wolters Kluwer Health

    Daniel Feaster

  59. Capturing drug use patterns at a glance: An n-ary word sufficient statistic for repeated univariate categorical values

    Article • PLOS One, September 2023, PLOS

    Daniel Feaster

  60. Geo-spatial risk factor analysis for drug overdose death in South Florida from 2014 to 2019, and the independent contribution of social determinants of health

    Article • Drug and Alcohol Dependence, July 2023, Elsevier

    Daniel Feaster

  61. Functions of Resiliency Traits and Processes in Differential Effects of CBSM on Quality of Life in Breast Cancer Survivors: A Moderated Mediation Model

    Article • International Journal of Behavioral Medicine, June 2023, Springer Science + Business Media

    Daniel Feaster

  62. A study protocol for Project I-Test: a cluster randomized controlled trial of a practice coaching intervention to increase HIV testing in substance use treatment programs

    Article • June 2023, Springer Science + Business Media

    Daniel Feaster

  63. Health Care Provider Stigma Toward Patients With Substance Use Disorders: Protocol for a Nationally Representative Survey (Preprint)

    Article • May 2023, JMIR Publications Inc.

    Daniel Feaster

  64. High suicidality predicts overdose events among people with substance use disorder: A latent class analysis

    Article • Frontiers in Public Health, May 2023, Frontiers

    Daniel Feaster

  65. Risk of Experiencing an Overdose Event for Patients Undergoing Treatment With Medication for Opioid Use Disorder

    Article • American Journal of Psychiatry, May 2023, American Psychiatric Association

    Daniel Feaster

  66. Structural equation model of intersectional microaggressions, discrimination, resilience, and mental health among black women with hiv.

    Article • Health Psychology, May 2023, American Psychological Association (APA)

    Daniel Feaster

  67. Untreated substance use disorder affects glycemic control: Results in patients with type 2 diabetes served within a network of community-based healthcare centers in Florida

    Article • Frontiers in Public Health, March 2023, Frontiers

    Daniel Feaster

  68. Project T-SHARP: study protocol for a multi-site randomized controlled trial of tele-harm reduction for people with HIV who inject drugs

    Article • Trials, February 2023, Springer Science + Business Media

    Daniel Feaster

  69. Strategies of Managing Repeated Measures: Using Synthetic Random Forest to Predict HIV Viral Suppression Status Among Hospitalized Persons with HIV

    Article • AIDS and Behavior, February 2023, Springer Science + Business Media

    Daniel Feaster

  70. Assessing HIV Care Outcomes Among Persons Who Use Drugs in Puerto Rico Before and After Hurricane Maria

    Article • Disaster Medicine and Public Health Preparedness, January 2023, Cambridge University Press

    Daniel Feaster

  71. Differential Effects of Patient Navigation across Latent Profiles of Barriers to Care among People Living with HIV and Comorbid Conditions

    Article • Journal of Clinical Medicine, December 2022, MDPI AG

    Daniel Feaster

  72. Integrated Infectious Disease and Substance Use Disorder Care for the Treatment of Injection Drug Use–Associated Infections: A Prospective Cohort Study With Historical Control

    Article • Open Forum Infectious Diseases, December 2022, Oxford University Press (OUP)

    Daniel Feaster

  73. Impacts of the New York State COVID‐19 disaster emergency orders on prescription dispensing for opioids and medication for opioid use disorder

    Article • Addiction, December 2022, Wiley

    Daniel Feaster

  74. Impact of COVID-19 on HIV service delivery in Miami-Dade County: a mixed methods study

    Article • BMC Health Services Research, December 2022, Springer Science + Business Media

    Daniel Feaster

  75. Effectiveness of an Intervention to Improve HIV Service Delivery for People Who Inject Drugs in Kazakhstan

    Article • JAMA Network Open, December 2022, American Medical Association (AMA)

    Daniel Feaster

  76. Specific polysubstance use patterns predict relapse among patients entering opioid use disorder treatment

    Article • Drug and Alcohol Dependence Reports, December 2022, Elsevier

    Daniel Feaster

  77. Suicidality as a Predictor of Overdose among Patients with Substance Use Disorders

    Article • Journal of Clinical Medicine, October 2022, MDPI AG

    Daniel Feaster

  78. Correction: M2HepPrEP: study protocol for a multi-site multi-setting randomized controlled trial of integrated HIV prevention and HCV care for PWID

    Article • Trials, September 2022, Springer Science + Business Media

    Daniel Feaster

  79. Ending the HIV Epidemic for Persons Left Behind in the Advances of HIV: Intervention Studies Addressing the HIV Continuum of Care

    Article • Research on Social Work Practice, September 2022, SAGE Publications

    Daniel Feaster

  80. Performance of model-based vs. permutation tests in the HEALing (Helping to End Addiction Long-termSM) Communities Study, a covariate-constrained cluster randomized trial

    Article • Trials, September 2022, Springer Science + Business Media

    Daniel Feaster

  81. Qualitative System Dynamics Modeling to Support Community Planning in Opioid Overdose Prevention

    Article • Research on Social Work Practice, September 2022, SAGE Publications

    Daniel Feaster

  82. Application of machine learning algorithms for localized syringe services program policy implementation – Florida, 2017

    Article • Annals of Medicine, July 2022, Taylor & Francis

    Daniel Feaster

  83. Neighborhood Characteristics, Intersectional Discrimination, Mental Health, and HIV Outcomes Among Black Women Living With HIV, Southeastern United States, 2019‒2020

    Article • American Journal of Public Health, June 2022, American Public Health Association

    Daniel Feaster

  84. What is the prevalence of and trend in opioid use disorder in the United States from 2010 to 2019? Using multiplier approaches to estimate prevalence for an unknown population size

    Article • Drug and Alcohol Dependence Reports, June 2022, Elsevier

    Daniel Feaster

  85. M2HepPrEP: study protocol for a multi-site multi-setting randomized controlled trial of integrated HIV prevention and HCV care for PWID

    Article • Trials, April 2022, Springer Science + Business Media

    Daniel Feaster

  86. Methamphetamine use among people who inject heroin in Hanoi, Vietnam

    Article • MedPharmRes, March 2022, University of Medicine and Pharmacy at Ho Chi Minh City

    Daniel Feaster

  87. Cost of Hepatitis C care facilitation for HIV/Hepatitis C Co-infected people who use drugs

    Article • Drug and Alcohol Dependence, March 2022, Elsevier

    Daniel Feaster

  88. Latent class analysis of loneliness and connectedness in US young adults during COVID‐19

    Article • Journal of Clinical Psychology, February 2022, Wiley

    Daniel Feaster

  89. Performance of Model-Based vs. Permutation Tests in the HEALing (Helping to End Addiction Long-TermSM) Communities Study, a Covariate Constrained Cluster Randomized Trial

    Article • February 2022, Springer Science + Business Media

    Daniel Feaster

  90. Human Immunodeficiency Virus transmission by HIV Risk Group and Along the HIV Care Continuum: A Contrast of 6 US Cities

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, February 2022, Wolters Kluwer Health

    Daniel Feaster

  91. Marginal modeling in community randomized trials with rare events: Utilization of the negative binomial regression model

    Article • Clinical Trials, January 2022, SAGE Publications

    Daniel Feaster

  92. Acceptability, feasibility, and pilot results of the tele-harm reduction intervention for rapid initiation of antiretrovirals among people who inject drugs

    Article • Drug and Alcohol Dependence, December 2021, Elsevier

    Daniel Feaster

  93. Implementation and first-year operating costs of an academic medical center-based syringe services program

    Article • Harm Reduction Journal, November 2021, Springer Science + Business Media

    Daniel Feaster

  94. The impact of the national stay-at-home order on emergency department visits for suspected opioid overdose during the first wave of the COVID-19 pandemic

    Article • Drug and Alcohol Dependence, November 2021, Elsevier

    Daniel Feaster

  95. Correlates of psychological intimate partner violence with HIV care outcomes on patients in HIV care

    Article • BMC Public Health, October 2021, Springer Science + Business Media

    Daniel Feaster

  96. Disparities in Opioid Overdose Death Trends by Race/Ethnicity, 2018–2019, From the HEALing Communities Study

    Article • American Journal of Public Health, October 2021, American Public Health Association

    Daniel Feaster

  97. Recruitment into a Clinical Trial of People Living with Uncontrolled HIV Infection Who Inject Drugs: a Site Case Report from the CTN 67 CHOICES Study

    Article • Gender Issues, September 2021, Springer Science + Business Media

    Daniel Feaster

  98. Improving health equity and ending the HIV epidemic in the USA: a distributional cost-effectiveness analysis in six cities

    Article • The Lancet HIV, September 2021, Elsevier

    Daniel Feaster

  99. An autoregressive cross-lagged model unraveling co-occurring stimulant use and HIV: Results from a randomized controlled trial

    Article • Drug and Alcohol Dependence, August 2021, Elsevier

    Daniel Feaster

  100. Reduction in injection risk behaviors after implementation of a syringe services program, Miami, Florida

    Article • Journal of Substance Abuse Treatment, August 2021, Elsevier

    Daniel Feaster

  101. Racial/Ethnic Disparities in the Incidence of Epithelial Ovarian Cancer in Florida by Histology, 2001–2015: Analysis of Trends

    Article • Southern Medical Journal, July 2021, Southern Medical Association

    Daniel Feaster

  102. Care Facilitation Advances Movement Along the Hepatitis C Care Continuum for Persons With Human Immunodeficiency Virus, Hepatitis C, and Substance Use: A Randomized Clinical Trial (CTN-0064)

    Article • Open Forum Infectious Diseases, June 2021, Oxford University Press (OUP)

    Daniel Feaster

  103. Efficacy of a Family-Based Intervention for HIV Prevention with Hispanic Adolescents with Same Gender Sexual Behaviors

    Article • Prevention Science, June 2021, Springer Science + Business Media

    Daniel Feaster

  104. Understanding Willingness to Participate in HIV Biomedical Research: A Mixed Methods Investigation

    Article • AIDS and Behavior, June 2021, Springer Science + Business Media

    Daniel Feaster

  105. LGB-Affirming School Climates and Sexual Health Outcomes Among U.S. High School Students 2015–2017: Differences by Sex and Sexual Identity

    Article • Journal of Adolescent Health, June 2021, Elsevier

    Daniel Feaster

  106. Daily Microaggressions and Related Distress among Black Women Living with HIV during the Onset of the COVID-19 Pandemic and Black Lives Matter Protests

    Article • AIDS and Behavior, May 2021, Springer Science + Business Media

    Daniel Feaster

  107. Harmonizing healthcare and other resource measures for evaluating economic costs in substance use disorder research

    Article • Substance Abuse Treatment Prevention and Policy, April 2021, Springer Science + Business Media

    Daniel Feaster

  108. DIY Antenna Studio: A Cost-Effective Tool for Antenna Analysis [Education Corner]

    Article • IEEE Antennas and Propagation Magazine, April 2021, Institute of Electrical & Electronics Engineers (IEEE)

    Daniel Feaster

  109. Self-efficacy as a mediator of patient navigation interventions to engage persons living with HIV and substance use

    Article • Drug and Alcohol Dependence, April 2021, Elsevier

    Daniel Feaster

  110. Blue Monday: Co-occurring Stimulant Use and HIV Persistence Predict Dysregulated Catecholamine Synthesis

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, March 2021, Wolters Kluwer Health

    Daniel Feaster

  111. Multimorbidity patterns and their relationship to mortality in the US older adult population

    Article • PLOS One, January 2021, PLOS

    Daniel Feaster

  112. Tryptophan depletion predicts lower positive affect in sexual minority men living with HIV who use methamphetamine

    Article • Journal of NeuroVirology, January 2021, Springer Science + Business Media

    Daniel Feaster

  113. Dyadic analysis of criminal justice involvement and hiv risks among couples who inject drugs and their intimate partners in almaty, kazakhstan

    Article • International Journal of Drug Policy, January 2021, Elsevier

    Daniel Feaster

  114. Operationalizing and selecting outcome measures for the HEALing Communities Study

    Article • Drug and Alcohol Dependence, December 2020, Elsevier

    Daniel Feaster

  115. The HEALing (Helping to End Addiction Long-term SM) Communities Study: Protocol for a cluster randomized trial at the community level to reduce opioid overdose deaths through implementation of an integrated set of evidence-based practices

    Article • Drug and Alcohol Dependence, December 2020, Elsevier

    Daniel Feaster

  116. Loneliness, Mental Health, and Substance Use among US Young Adults during COVID-19

    Article • Journal of Psychoactive Drugs, October 2020, Taylor & Francis

    Daniel Feaster

  117. Trauma exposure, PTSD, and suboptimal HIV medication adherence among marginalized individuals connected to public HIV care in Miami

    Article • Journal of Behavioral Medicine, October 2020, Springer Science + Business Media

    Daniel Feaster

  118. A Dyadic Analysis of Criminal Justice Involvement and Sexual HIV Risk Behaviors Among Drug-Involved Men in Community Corrections and Their Intimate Partners in New York City: Implications for Prevention, Treatment and Policies

    Article • AIDS and Behavior, October 2020, Springer Science + Business Media

    Daniel Feaster

  119. Women's HIV disclosure to the dentist: Does frequent contact matter?

    Article • Journal of Public Health Dentistry, October 2020, Wiley

    Daniel Feaster

  120. The Potential Epidemiological Impact of Coronavirus Disease 2019 (COVID-19) on the Human Immunodeficiency Virus (HIV) Epidemic and the Cost-effectiveness of Linked, Opt-out HIV Testing: A Modeling Study in 6 US Cities

    Article • Clinical Infectious Diseases, October 2020, Oxford University Press (OUP)

    Daniel Feaster

  121. Hazardous alcohol use, antiretroviral therapy receipt, and viral suppression in people living with HIV who inject drugs in the United States, India, Russia, and Vietnam

    Article • AIDS, October 2020, Wolters Kluwer Health

    Daniel Feaster

  122. Impact of routine opt-out HIV/HCV screening on testing uptake at a syringe services program: An interrupted time series analysis

    Article • International Journal of Drug Policy, October 2020, Elsevier

    Daniel Feaster

  123. Ending the HIV Epidemic Among Persons Who Inject Drugs: A Cost-Effectiveness Analysis in Six US Cities

    Article • The Journal of Infectious Diseases, September 2020, Oxford University Press (OUP)

    Daniel Feaster

  124. Association of negative financial shocks during the Great Recession with depressive symptoms and substance use in the USA: the CARDIA study

    Article • Journal of Epidemiology & Community Health, August 2020, BMJ

    Daniel Feaster

  125. Can the ‘Ending the HIV Epidemic’ initiative transition the USA towards HIV/AIDS epidemic control?

    Article • AIDS, August 2020, Wolters Kluwer Health

    Daniel Feaster

  126. Dental Care Utilization of Hospitalized Persons Living with HIV and Substance Use

    Article • Journal of Community Health, August 2020, Springer Science + Business Media

    Daniel Feaster

  127. Dissemination Science to Advance the Use of Simulation Modeling: Our Obligation Moving Forward

    Article • Medical Decision Making, August 2020, SAGE Publications

    Daniel Feaster

  128. The Relationship Between Housing Status and Substance Use and Sexual Risk Behaviors Among People Currently Seeking or Receiving Services in Substance Use Disorder Treatment Programs

    Article • The Journal of Primary Prevention, July 2020, Springer Science + Business Media

    Daniel Feaster

  129. Chronic condition patterns in the US population and their association with health related quality of life

    Article • Preventive Medicine, July 2020, Elsevier

    Daniel Feaster

  130. Ending the HIV epidemic in the USA: an economic modelling study in six cities

    Article • The Lancet HIV, July 2020, Elsevier

    Daniel Feaster

  131. Oral health–related quality of life and unmet dental needs among women living with HIV

    Article • The Journal of the American Dental Association, July 2020, Elsevier

    Daniel Feaster

  132. New Statistical Methods to Assess How Patients with Different Traits Respond to the Same Treatment

    Article • June 2020, Patient-Centered Outcomes Reserach Institute

    Daniel Feaster

  133. Initiation of Antiretroviral Therapy in the Hospital Is Associated With Linkage to Human Immunodeficiency Virus (HIV) Care for Persons Living With HIV and Substance Use Disorder

    Article • Clinical Infectious Diseases, June 2020, Oxford University Press (OUP)

    Daniel Feaster

  134. Problem opioid use and HIV primary care engagement among hospitalized people who use drugs and/or alcohol

    Article • Addiction Science & Clinical Practice, June 2020, Springer Science + Business Media

    Daniel Feaster

  135. Baseline prevalence and correlates of HIV and HCV infection among people who inject drugs accessing a syringe services program; Miami, FL

    Article • Harm Reduction Journal, June 2020, Springer Science + Business Media

    Daniel Feaster

  136. Residential segregation and overall survival of women with epithelial ovarian cancer

    Article • Cancer, June 2020, Wiley

    Daniel Feaster

  137. The Disaggregated Repeated Measures Design: A Novel Approach to Assess Sexual Risk Behaviors

    Article • Archives of Sexual Behavior, May 2020, Springer Science + Business Media

    Daniel Feaster

  138. “Ending the Epidemic” Will Not Happen Without Addressing Racial/Ethnic Disparities in the United States Human Immunodeficiency Virus Epidemic

    Article • Clinical Infectious Diseases, May 2020, Oxford University Press (OUP)

    Daniel Feaster

  139. Predictors for Poor Linkage to Care Among Hospitalized Persons Living with HIV and Co-Occurring Substance Use Disorder

    Article • AIDS Research and Human Retroviruses, April 2020, SAGE Publications

    Daniel Feaster

  140. Examining risk behavior and syringe coverage among people who inject drugs accessing a syringe services program: A latent class analysis

    Article • International Journal of Drug Policy, April 2020, Elsevier

    Daniel Feaster

  141. Patterns of Chronic Conditions and Their Association With Visual Impairment and Health Care Use

    Article • JAMA Ophthalmology, April 2020, American Medical Association (AMA)

    Daniel Feaster

  142. The impact of localized implementation: determining the cost-effectiveness of HIV prevention and care interventions across six United States cities

    Article • AIDS, March 2020, Wolters Kluwer Health

    Daniel Feaster

  143. Racial and ethnic disparities in the overall survival of women with epithelial ovarian cancer in Florida, 2001–2015

    Article • Cancer Causes & Control, February 2020, Springer Science + Business Media

    Daniel Feaster

  144. Bundling Rapid Human Immunodeficiency Virus and Hepatitis C Virus Testing to Increase Receipt of Test Results

    Article • Medical Care, February 2020, Wolters Kluwer Health

    Daniel Feaster

  145. The Potential Epidemiological Impact of COVID-19 on the HIV/AIDS Epidemic and the Cost-Effectiveness of Linked, Opt-Out HIV Testing: A Modeling Study in Six US Cities

    Article • SSRN Electronic Journal, January 2020, Elsevier

    Daniel Feaster

  146. Development and Calibration of a Dynamic HIV Transmission Model for 6 US Cities

    Article • Medical Decision Making, December 2019, SAGE Publications

    Daniel Feaster

  147. Racial discrimination in medical care settings and opioid pain reliever misuse in a U.S. cohort: 1992 to 2015

    Article • PLOS One, December 2019, PLOS

    Daniel Feaster

  148. Randomized controlled trial of a positive affect intervention to reduce HIV viral load among sexual minority men who use methamphetamine

    Article • Journal of the International AIDS Society, December 2019, Wiley

    Daniel Feaster

  149. Ending the Epidemic in America Will Not Happen if the Status Quo Continues: Modeled Projections for Human Immunodeficiency Virus Incidence in 6 US Cities

    Article • Clinical Infectious Diseases, October 2019, Oxford University Press (OUP)

    Daniel Feaster

  150. Enhancing patient navigation with contingent financial incentives for substance use abatement in persons with HIV and substance use.

    Article • Psychology of Addictive Behaviors, August 2019, American Psychological Association (APA)

    Daniel Feaster

  151. Dental insurance, dental care utilization, and perceived unmet dental needs in women living with HIV: Results from the Women's Interagency HIV Study

    Article • Journal of Public Health Dentistry, August 2019, Wiley

    Daniel Feaster

  152. Pilot Randomized Controlled Trial of a Syndemics Intervention with HIV-Positive, Cocaine-Using Women

    Article • AIDS and Behavior, August 2019, Springer Science + Business Media

    Daniel Feaster

  153. High Levels of Syndemics and Their Association with Adherence, Viral Non-suppression, and Biobehavioral Transmission Risk in Miami, a U.S. City with an HIV/AIDS Epidemic

    Article • AIDS and Behavior, August 2019, Springer Science + Business Media

    Dr. Prof. Lunthita M Duthely, Daniel Feaster

  154. The roles of heavy drinking and drug use in engagement in HIV care among hospitalized substance using individuals with poorly controlled HIV infection

    Article • Drug and Alcohol Dependence, August 2019, Elsevier

    Daniel Feaster

  155. Pre-exposure prophylaxis access in federally qualified health centers across 11 United States metropolitan statistical areas

    Article • International Journal of STD & AIDS, July 2019, SAGE Publications

    Daniel Feaster

  156. Structural Design and Data Requirements for Simulation Modelling in HIV/AIDS: A Narrative Review

    Article • PharmacoEconomics, June 2019, Springer Science + Business Media

    Daniel Feaster

  157. Improving HIV service delivery for people who inject drugs in Kazakhstan: study protocol for the Bridge stepped-wedge trial

    Article • Implementation Science, June 2019, Springer Science + Business Media

    Daniel Feaster

  158. Viral suppression and HIV transmission behaviors among hospitalized patients living with HIV

    Article • International Journal of STD & AIDS, June 2019, SAGE Publications

    Yue Pan, Daniel Feaster

  159. Repeated measures regression mixture models

    Article • Behavior Research Methods, May 2019, Springer Science + Business Media

    Daniel Feaster

  160. Developing a dynamic HIV transmission model for 6 U.S. cities: An evidence synthesis

    Article • PLOS One, May 2019, PLOS

    Daniel Feaster

  161. Health Disparities and the Digital Divide: The Relationship between Communication Inequalities and Quality of Life among Women in a Nationwide Prospective Cohort Study in the United States

    Article • Journal of Health Communication, April 2019, Taylor & Francis

    Dr Carrigan Leigh Parish, Daniel Feaster

  162. Dentists’ willingness to screen for cardiovascular disease in the dental care setting: Findings from a nationally representative survey

    Article • Community Dentistry And Oral Epidemiology, March 2019, Wiley

    Daniel Feaster

  163. Physician Mistrust, Medical System Mistrust, and Perceived Discrimination: Associations with HIV Care Engagement and Viral Load

    Article • AIDS and Behavior, March 2019, Springer Science + Business Media

    Daniel Feaster

  164. Clinical and Sociobehavioral Prediction Model of 30-Day Hospital Readmissions Among People With HIV and Substance Use Disorder: Beyond Electronic Health Record Data

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, March 2019, Wolters Kluwer Health

    Daniel Feaster

  165. High Dimensional Latent Space Variational AutoEncoders for Fake News Detection

    Article • March 2019, Institute of Electrical & Electronics Engineers (IEEE)

    Daniel Feaster

  166. A Randomized Study of Passive versus Active PrEP Patient Navigation for a Heterogeneous Population at Risk for HIV in South Florida

    Article • Journal of the International Association of Providers of AIDS Care (JIAPAC), January 2019, SAGE Publications

    Daniel Feaster

  167. Approaches for creating comparable measures of alcohol use symptoms: Harmonization with eight studies of criminal justice populations

    Article • Drug and Alcohol Dependence, January 2019, Elsevier

    Daniel Feaster

  168. Why Maximizing Quality-Adjusted Life Years, rather than Reducing HIV Incidence, Must Remain Our Objective in Addressing the HIV/AIDS Epidemic

    Article • Journal of the International Association of Providers of AIDS Care (JIAPAC), January 2019, SAGE Publications

    Daniel Feaster

  169. How patient navigators view the use of financial incentives to influence study involvement, substance use, and HIV treatment

    Article • Journal of Substance Abuse Treatment, November 2018, Elsevier

    Daniel Feaster

  170. Counterfactual Autoencoder for Unsupervised Semantic Learning

    Article • International Journal of Multimedia Data Engineering and Management, October 2018, IGI Global

    Daniel Feaster

  171. Criminal justice measures for economic data harmonization in substance use disorder research

    Article • Health & Justice, September 2018, Springer Science + Business Media

    Daniel Feaster

  172. Patterns and Correlates of Participant Retention in a Multi-City Pre-Exposure Prophylaxis Demonstration Project

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, September 2018, Wolters Kluwer Health

    Daniel Feaster

  173. The Effects of Sample Size on the Estimation of Regression Mixture Models

    Article • Educational and Psychological Measurement, August 2018, SAGE Publications

    Daniel Feaster

  174. The association of periodontal disease and cardiovascular disease risk: Results from the Hispanic Community Health Study/Study of Latinos

    Article • The Journal of Periodontology, July 2018, Wiley

    Daniel Feaster

  175. Acute HIV Discovered During Routine HIV Screening With HIV Antigen-Antibody Combination Tests in 9 US Emergency Departments

    Article • Annals of Emergency Medicine, July 2018, Elsevier

    Daniel Feaster

  176. Enhancing Patient Navigation with Contingent Incentives to Improve Healthcare Behaviors and Viral Load Suppression of Persons with HIV and Substance Use

    Article • AIDS Patient Care and STDs, July 2018, SAGE Publications

    Daniel Feaster

  177. The North-South Divide: Substance Use Risk, Care Engagement, and Viral Suppression Among Hospitalized Human Immunodeficiency Virus–Infected Patients in 11 US Cities

    Article • Clinical Infectious Diseases, June 2018, Oxford University Press (OUP)

    Daniel Feaster

  178. Building the Case for Localized Approaches to HIV: Structural Conditions and Health System Capacity to Address the HIV/AIDS Epidemic in Six US Cities

    Article • AIDS and Behavior, May 2018, Springer Science + Business Media

    Daniel Feaster

  179. Missed Opportunities for HIV Testing Among STD Clinic Patients

    Article • Journal of Community Health, May 2018, Springer Science + Business Media

    Daniel Feaster

  180. Psychosocial Factors Associated with Problem Drinking Among Substance Users with Poorly Controlled HIV Infection

    Article • Alcohol and Alcoholism, March 2018, Oxford University Press (OUP)

    Daniel Feaster

  181. Patterns of Substance Use and Arrest Histories Among Hospitalized HIV Drug Users: A Latent Class Analysis

    Article • AIDS and Behavior, January 2018, Springer Science + Business Media

    Daniel Feaster

  182. Baseline Cigarette Smoking Status as a Predictor of Virologic Suppression and CD4 Cell Count During One-Year Follow-Up in Substance Users with Uncontrolled HIV Infection

    Article • AIDS and Behavior, October 2017, Springer Science + Business Media

    Daniel Feaster

  183. The analysis of bridging constructs with hierarchical clustering methods: An application to identity

    Article • Journal of Research in Personality, October 2017, Elsevier

    Daniel Feaster

  184. When “the Cure” Is the Risk: Understanding How Substance Use Affects HIV and HCV in a Layered Risk Environment in San Juan, Puerto Rico

    Article • Health Education & Behavior, September 2017, SAGE Publications

    Daniel Feaster

  185. Correlates of Unknown HIV Status Among MSM Participating in the 2014 American Men’s Internet Survey (AMIS)

    Article • AIDS and Behavior, August 2017, Springer Science + Business Media

    Daniel Feaster

  186. AAFA: Associative Affinity Factor Analysis for Bot Detection and Stance Classification in Twitter

    Article • August 2017, Institute of Electrical & Electronics Engineers (IEEE)

    Daniel Feaster

  187. Enhancing patient navigation to improve intervention session attendance and viral load suppression of persons with HIV and substance use: a secondary post hoc analysis of the Project HOPE study

    Article • Addiction Science & Clinical Practice, June 2017, Springer Science + Business Media

    Daniel Feaster

  188. Effects of Antiretroviral Therapy and Depressive Symptoms on All-Cause Mortality Among HIV-Infected Women

    Article • American Journal of Epidemiology, April 2017, Oxford University Press (OUP)

    Daniel Feaster

  189. Healthcare Access and PrEP Continuation in San Francisco and Miami After the US PrEP Demo Project

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, April 2017, Wolters Kluwer Health

    Daniel Feaster

  190. The structural and health policy environment for delivering integrated HIV and substance use disorder treatments in Puerto Rico

    Article • BMC Health Services Research, March 2017, Springer Science + Business Media

    Daniel Feaster

  191. Association Between Socio-Ecological Risk Factor Clustering and Mental, Emotional, and Behavioral Problems in Hispanic Adolescents

    Article • Journal of Child and Family Studies, March 2017, Springer Science + Business Media

    Daniel Feaster

  192. Patterns of substance use and arrest among hospitalized people living with HIV: A latent class analysis

    Article • Drug and Alcohol Dependence, February 2017, Elsevier

    Daniel Feaster

  193. Motivational enhancement treatment in outpatient addiction centers: A multisite randomized trial

    Article • International Journal of Clinical and Health Psychology, January 2017, Elsevier

    Daniel Feaster

  194. Factors Associated with HIV Testing Among Participants from Substance Use Disorder Treatment Programs in the US: A Machine Learning Approach

    Article • AIDS and Behavior, December 2016, Springer Science + Business Media

    Daniel Feaster

  195. Centering Predictor Variables in Three-Level Contextual Models

    Article • Multivariate Behavioral Research, December 2016, Taylor & Francis

    Daniel Feaster

  196. Substance use and STI acquisition: Secondary analysis from the AWARE study

    Article • Drug and Alcohol Dependence, December 2016, Elsevier

    Daniel Feaster

  197. Substance Use and Sexual Risk Behavior in Sexual Minority Hispanic Adolescents

    Article • Journal of Adolescent Health, November 2016, Elsevier

    Daniel Feaster

  198. Effect of Patient Navigation With or Without Financial Incentives on Viral Suppression Among Hospitalized Patients With HIV Infection and Substance Use

    Article • JAMA, July 2016, American Medical Association (AMA)

    Daniel Feaster

  199. Neighborhood Greenness and Chronic Health Conditions in Medicare Beneficiaries

    Article • American Journal of Preventive Medicine, July 2016, Elsevier

    Daniel Feaster

  200. Readiness and barriers to adopt evidence-based practices for substance abuse treatment in Mexico

    Article • Salud Mental, March 2016, Instituto Nacional de Psiquiatria Ramon de la Fuente Muniz

    Daniel Feaster

  201. Identification of predicted individual treatment effects in randomized clinical trials

    Article • Statistical Methods in Medical Research, March 2016, SAGE Publications

    Daniel Feaster

  202. Actor–Partner Effects of Male Couples Substance Use with Sex and Engagement in Condomless Anal Sex

    Article • AIDS and Behavior, March 2016, Springer Science + Business Media

    Daniel Feaster

  203. On-site bundled rapid HIV/HCV testing in substance use disorder treatment programs: study protocol for a hybrid design randomized controlled trial

    Article • Trials, March 2016, Springer Science + Business Media

    Daniel Feaster

  204. Gender Differences in HIV Sexual Risk Behaviors Among Clients of Substance Use Disorder Treatment Programs in the U.S.

    Article • Archives of Sexual Behavior, February 2016, Springer Science + Business Media

    Daniel Feaster

  205. Examining the Efficacy of HIV Risk-Reduction Counseling on the Sexual Risk Behaviors of a National Sample of Drug Abuse Treatment Clients: Analysis of Subgroups

    Article • AIDS and Behavior, February 2016, Springer Science + Business Media

    Daniel Feaster

  206. Preexposure Prophylaxis for HIV Infection Integrated With Municipal- and Community-Based Sexual Health Services

    Article • JAMA Internal Medicine, January 2016, American Medical Association (AMA)

    Daniel Feaster

  207. Understanding HIV Care Provider Attitudes Regarding Intentions to Prescribe PrEP

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, December 2015, Wolters Kluwer Health

    Daniel Feaster

  208. Substance Use, Depression and Sociodemographic Determinants of HIV Sexual Risk Behavior in Outpatient Substance Abuse Treatment Patients

    Article • Journal of Addiction Medicine, November 2015, Wolters Kluwer Health

    Daniel Feaster

  209. A cross‐sectional assessment of the long term effects of brief strategic family therapy for adolescent substance use

    Article • American Journal on Addictions, September 2015, Wiley

    Daniel Feaster

  210. Using Multilevel Regression Mixture Models to Identify Level-1 Heterogeneity in Level-2 Effects

    Article • Structural Equation Modeling A Multidisciplinary Journal, August 2015, Taylor & Francis

    Daniel Feaster

  211. Impact of an equality constraint on the class-specific residual variances in regression mixtures: A Monte Carlo simulation study

    Article • Behavior Research Methods, July 2015, Springer Science + Business Media

    Daniel Feaster

  212. The incidence ofTrichomonas vaginalisinfection in women attending nine sexually transmitted diseases clinics in the USA: Table 1

    Article • Sexually Transmitted Infections, June 2015, BMJ

    Daniel Feaster

  213. Self-Reported HIV and HCV Screening Rates and Serostatus Among Substance Abuse Treatment Patients

    Article • AIDS and Behavior, May 2015, Springer Science + Business Media

    Daniel Feaster

  214. Age Differences in the Trends of Smoking Among California Adults: Results from the California Health Interview Survey 2001–2012

    Article • Journal of Community Health, May 2015, Springer Science + Business Media

    Daniel Feaster

  215. Association of Individual and Systemic Barriers to Optimal Medical Care in People Living With HIV/AIDS in Miami-Dade County

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, May 2015, Wolters Kluwer Health

    Daniel Feaster

  216. High Interest in Preexposure Prophylaxis Among Men Who Have Sex With Men at Risk for HIV Infection

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, April 2015, Wolters Kluwer Health

    Daniel Feaster

  217. The effects of Brief Strategic Family Therapy (BSFT) on parent substance use and the association between parent and adolescent substance use

    Article • Addictive Behaviors, March 2015, Elsevier

    Daniel Feaster

  218. Cost‐effectiveness of rapid hepatitis C virus ( HCV ) testing and simultaneous rapid HCV and ...

    Article • Addiction, December 2014, Wiley

    Daniel Feaster

  219. Evaluating Differential Effects Using Regression Interactions and Regression Mixture Models

    Article • Educational and Psychological Measurement, October 2014, SAGE Publications

    Daniel Feaster

  220. The Cost of Implementing Rapid HIV Testing in Sexually Transmitted Disease Clinics in the United States

    Article • Sexually Transmitted Diseases, September 2014, Wolters Kluwer Health

    Daniel Feaster

  221. Uptake of HIV Testing in Substance Use Disorder Treatment Programs That Offer On-Site Testing

    Article • AIDS and Behavior, July 2014, Springer Science + Business Media

    Daniel Feaster

  222. Characteristics of a Treatment-Seeking Population in Outpatient Addiction Treatment Centers in Mexico

    Article • Substance Use & Misuse, July 2014, Taylor & Francis

    Daniel Feaster

  223. Applying Spatial Analysis Tools in Public Health: An Example Using SaTScan to Detect Geographic Targets for Colorectal Cancer Screening Interventions

    Article • Preventing Chronic Disease, March 2014, Centers for Disease Control and Prevention - Preventing Chronic Disease

    Daniel Feaster

  224. Health correlates of co-occurring substance use for women with HIV in cocaine use recovery

    Article • Addictive Behaviors, March 2014, Elsevier

    Daniel Feaster

  225. Finite Mixtures for Simultaneously Modeling Differential Effects and Nonnormal Distributions

    Article • Multivariate Behavioral Research, November 2013, Taylor & Francis

    Daniel Feaster

  226. HIV Medical Providers' Perceptions of the Use of Antiretroviral Therapy as Nonoccupational Postexposure Prophylaxis in 2 Major Metropolitan Areas

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, November 2013, Wolters Kluwer Health

    Daniel Feaster

  227. Effect of Risk-Reduction Counseling With Rapid HIV Testing on Risk of Acquiring Sexually Transmitted Infections

    Article • JAMA, October 2013, American Medical Association (AMA)

    Daniel Feaster

  228. Health Status, Sexual and Drug Risk, and Psychosocial Factors Relevant to Postrelease Planning for HIV+ Prisoners

    Article • Journal of Correctional Health Care, October 2013, SAGE Publications

    Daniel Feaster

  229. An Ecosystem-Based Intervention to Reduce HIV Transmission Risk and Increase Medication Adherence Among Inmates Being Released to the Community

    Article • Journal of Correctional Health Care, July 2013, SAGE Publications

    Daniel Feaster

  230. O02.4 Persistent/Recurrent Chlamydial Infection Among STD Clinic Patients Treated with CDC-Recommended Therapies

    Article • Sexually Transmitted Infections, July 2013, BMJ

    Daniel Feaster

  231. P3.137 Rectal Lubricant Use & Incident STI Infections at 9 US STD Clinics

    Article • Sexually Transmitted Infections, July 2013, BMJ

    Daniel Feaster

  232. Reductions in Anxiety and Depression Symptoms in Youth Receiving Substance Use Treatment

    Article • American Journal on Addictions, June 2013, Wiley

    Daniel Feaster

  233. HIV rapid testing in drug treatment: comparison across treatment modalities

    Article • Journal of Substance Abuse Treatment, April 2013, Elsevier

    Daniel Feaster

  234. Using regression mixture models with non-normal data: examining an ordered polytomous approach

    Article • Journal of Statistical Computation and Simulation, April 2013, Taylor & Francis

    Daniel Feaster

  235. The cost-effectiveness of rapid HIV testing in substance abuse treatment: Results of a randomized trial

    Article • Drug and Alcohol Dependence, February 2013, Elsevier

    Daniel Feaster

  236. HIV testing rates among pregnant women in Managua, Nicaragua, 2010-2011

    Article • Revista Panamericana de Salud Pública, January 2013, FapUNIFESP (SciELO)

    Daniel Feaster

  237. Implementing Rapid HIV Testing With or Without Risk-Reduction Counseling in Drug Treatment Centers: Results of a Randomized Trial

    Article • American Journal of Public Health, June 2012, American Public Health Association

    Daniel Feaster

  238. Not Quite Normal: Consequences of Violating the Assumption of Normality in Regression Mixture Models

    Article • Structural Equation Modeling A Multidisciplinary Journal, April 2012, Taylor & Francis

    Daniel Feaster

  239. Injection behaviors among injection drug users in treatment: The role of hepatitis C awareness

    Article • Addictive Behaviors, April 2012, Elsevier

    Daniel Feaster

  240. Medical advice and diabetes self-management reported by Mexican-American, Black- and White-non-Hispanic adults across the United States

    Article • BMC Public Health, March 2012, Springer Science + Business Media

    Daniel Feaster

  241. Family mechanisms of structural ecosystems therapy for HIV-seropositive women in drug recovery.

    Article • Health Psychology, January 2012, American Psychological Association (APA)

    Daniel Feaster

  242. Course of Untreated High Blood Pressure in the Emergency Department

    Article • Western Journal of Emergency Medicine, November 2011, Western Journal of Emergency Medicine

    Daniel Feaster

  243. HIV rapid testing in substance abuse treatment: Implementation following a clinical trial

    Article • Evaluation and Program Planning, November 2011, Elsevier

    Daniel Feaster

  244. Conducting Research with Racial/Ethnic Minorities: Methodological Lessons from the NIDA Clinical Trials Network

    Article • The American Journal of Drug and Alcohol Abuse, August 2011, Taylor & Francis

    Daniel Feaster

  245. Modeling Site Effects in the Design and Analysis of Multi-site Trials

    Article • The American Journal of Drug and Alcohol Abuse, August 2011, Taylor & Francis

    Daniel Feaster

  246. NIDA’s Clinical Trials Network: An Opportunity for HIV Research in Community Substance Abuse Treatment Programs

    Article • The American Journal of Drug and Alcohol Abuse, August 2011, Taylor & Francis

    Daniel Feaster

  247. Multilevel Models to Identify Contextual Effects on Individual Group Member Outcomes: A Family Example

    Article • Family Process, May 2011, Wiley

    Daniel Feaster

  248. Intraclass Correlation Associated with Therapists: Estimates and Applications in Planning Psychotherapy Research

    Article • Cognitive Behaviour Therapy, March 2011, Taylor & Francis

    Professor Gerhard Andersson, Daniel Feaster

  249. Therapist adherence in brief strategic family therapy for adolescent drug abusers.

    Article • Journal of Consulting and Clinical Psychology, February 2011, American Psychological Association (APA)

    Daniel Feaster

  250. Brief strategic family therapy versus treatment as usual: Results of a multisite randomized trial for substance using adolescents.

    Article • Journal of Consulting and Clinical Psychology, January 2011, American Psychological Association (APA)

    Daniel Feaster

  251. Psychometric Characteristics and Race-Related Measurement Invariance of Stress and Coping Measures in Adults With HIV/AIDS

    Article • AIDS and Behavior, December 2010, Springer Science + Business Media

    Daniel Feaster

  252. The influence of health locus of control on the patient–provider relationship

    Article • Psychology Health & Medicine, December 2010, Taylor & Francis

    Daniel Feaster

  253. A Multilevel Mediation Model of Stress and Coping for Women with HIV and Their Families

    Article • Family Process, November 2010, Wiley

    Daniel Feaster

  254. Parent and Child Agreement on Anxiety Disorder Symptoms Using the DISC Predictive Scales

    Article • Assessment, November 2010, SAGE Publications

    Daniel Feaster

  255. A randomized controlled trial of Structural Ecosystems Therapy for HIV medication adherence and substance abuse relapse prevention

    Article • Drug and Alcohol Dependence, October 2010, Elsevier

    Daniel Feaster

  256. Multisite effectiveness trials of treatments for substance abuse and co-occurring problems: Have we chosen the best designs?

    Article • Journal of Substance Abuse Treatment, June 2010, Elsevier

    Kathleen Carroll, Daniel Feaster

  257. Equivalence of family functioning and externalizing behaviors in adolescent substance users of different race/ethnicity

    Article • Journal of Substance Abuse Treatment, June 2010, Elsevier

    Daniel Feaster

  258. Malaise, Motivation and Motherhood: Predictors of Engagement in Behavioral Interventions from a Randomized Controlled Trial for HIV+ Women in Drug Abuse Recovery

    Article • AIDS and Behavior, May 2010, Springer Science + Business Media

    Daniel Feaster

  259. Structural Ecosystems Therapy for HIV+ African‐American Women and Drug Abuse Relapse

    Article • Family Process, May 2010, Wiley

    Daniel Feaster

  260. Do therapist cultural characteristics influence the outcome of substance abuse treatment for Spanish-speaking adults?

    Article • Cultural Diversity and Ethnic Minority Psychology, January 2010, American Psychological Association (APA)

    Kathleen Carroll, Daniel Feaster

  261. Structural Ecosystems Therapy for recovering HIV-positive women: Child, mother, and parenting outcomes.

    Article • Journal of Family Psychology, January 2010, American Psychological Association (APA)

    Daniel Feaster

  262. The efficacy of Structural Ecosystems Therapy for HIV medication adherence with African American women.

    Article • Journal of Family Psychology, January 2010, American Psychological Association (APA)

    Daniel Feaster

  263. Choosing a control group in effectiveness trials of behavioral drug abuse treatments

    Article • Journal of Substance Abuse Treatment, December 2009, Elsevier

    Daniel Feaster

  264. Examining family networks of HIV+ women in drug recovery: Challenges and opportunities.

    Article • Families Systems & Health, September 2009, American Psychological Association (APA)

    Daniel Feaster

  265. Brief strategic family therapy™ for adolescent drug abusers: A multi-site effectiveness study

    Article • Contemporary Clinical Trials, May 2009, Elsevier

    Daniel Feaster

  266. Factors Related to Loss of Child Custody in HIV+ Women in Drug Abuse Recovery

    Article • The American Journal of Drug and Alcohol Abuse, January 2009, Taylor & Francis

    Daniel Feaster

  267. Measurement and data analysis in research addressing health disparities in substance abuse

    Article • Journal of Substance Abuse Treatment, January 2009, Elsevier

    Daniel Feaster

  268. Conflict Resolution and Distress in Dementia Caregiver Families: Comparison of Cubans and White Non-Hispanics

    Article • Hispanic Health Care International, June 2008, Springer Publishing Company

    Daniel Feaster

  269. The efficacy of structural ecosystems therapy with drug-abusing/dependent African American and Hispanic American adolescents.

    Article • Journal of Family Psychology, January 2008, American Psychological Association (APA)

    Dr. Frank R Dillon, Daniel Feaster

  270. A randomized controlled trial of a parent-centered intervention in preventing substance use and HIV risk behaviors in Hispanic adolescents.

    Article • Journal of Consulting and Clinical Psychology, December 2007, American Psychological Association (APA)

    Daniel Feaster

  271. Stress processes in HIV-positive African American mothers: Moderating effects of drug abuse history

    Article • Anxiety Stress & Coping, November 2007, Taylor & Francis

    Daniel Feaster

  272. The impact of family functioning on family racial socialization processes.

    Article • Cultural Diversity and Ethnic Minority Psychology, January 2007, American Psychological Association (APA)

    Dr. Frank R Dillon, Daniel Feaster

  273. Increasing Minority Research Participation Through Community Organization Outreach

    Article • Western Journal of Nursing Research, August 2006, SAGE Publications

    Daniel Feaster

  274. The Role of Family Functioning in the Stress Process of Dementia Caregivers: A Structural Family Framework

    Article • The Gerontologist, February 2006, Oxford University Press (OUP)

    Daniel Feaster

  275. Adapting the Structural Family Systems Rating to Assess the Patterns of Interaction in Families of Dementia Caregivers

    Article • The Gerontologist, August 2005, Oxford University Press (OUP)

    Daniel Feaster

  276. Searching for an efficient institutional review board review model: Interrelationship of trainee-investigators, funding, and initial approval

    Article • Journal of Laboratory and Clinical Medicine, February 2005, Elsevier

    Daniel Feaster

  277. Statistical issues in multisite effectiveness trials: the case of brief strategic family therapy for adolescent drug abuse treatment

    Article • Clinical Trials, October 2004, SAGE Publications

    Daniel Feaster

  278. Religious Involvement, Coping, Social Support, and Psychological Distress in HIV-Seropositive African American Mothers

    Article • AIDS and Behavior, September 2004, Springer Science + Business Media

    Daniel Feaster

  279. Structural Ecosystems Therapy for HIV-Seropositive African American Women: Effects on Psychological Distress, Family Hassles, and Family Support.

    Article • Journal of Consulting and Clinical Psychology, January 2004, American Psychological Association (APA)

    Daniel Feaster

  280. Longitudinal analysis when the experimenter does not determine when treatment ends: what is dose–response?

    Article • Clinical Psychology & Psychotherapy, November 2003, Wiley

    Daniel Feaster

  281. Relational Factors and Family Treatment Engagement among Low-Income, HIV-Positive African American Mothers

    Article • Family Process, March 2003, Wiley

    Daniel Feaster

  282. Posttraumatic Stress Disorder Symptoms in Hispanic Immigrants After the September 11th Attacks: Severity and Relationship to Previous Traumatic Exposure

    Article • Hispanic Journal of Behavioral Sciences, February 2003, SAGE Publications

    Daniel Feaster

  283. Equivalence to normal?

    Article • Journal of Clinical Psychology, January 2003, Wiley

    Daniel Feaster

  284. Article • Prevention Science, January 2003, Springer Science + Business Media

    Daniel Feaster

  285. Predicting protected sexual behaviour using the Information-Motivation-Behaviour skills model among adolescent substance abusers in court-ordered treatment

    Article • Psychology Health & Medicine, August 2002, Taylor & Francis

    Daniel Feaster

  286. Ethnic Differences in Comorbidity Among Substance-Abusing Adolescents Referred to Outpatient Therapy

    Article • Journal of the American Academy of Child & Adolescent Psychiatry, April 2002, Elsevier

    Daniel Feaster

  287. Interdependence of Stress Processes Among African American Family Members: Influence of HIV Serostatus and a New Infant

    Article • Psychology & Health, January 2002, Taylor & Francis

    Daniel Feaster

  288. Article • AIDS and Behavior, January 2002, Springer Science + Business Media

    Daniel Feaster

  289. Article • Journal of the Gay and Lesbian Medical Association, January 2002, Springer Science + Business Media

    Daniel Feaster

  290. The Psychosocial Functioning of HIV+ and HIV− African American Recent Mothers

    Article • AIDS and Behavior, September 2001, Springer Science + Business Media

    Daniel Feaster

  291. A Randomized Controlled Clinical Trial of a Bereavement Support Group Intervention in Human Immunodeficiency Virus Type 1–Seropositive and –Seronegative Homosexual Men

    Article • Archives of General Psychiatry, January 1999, American Medical Association (AMA)

    Daniel Feaster

  292. BEREAVEMENT HISTORY AND PSYCHOSOCIAL FACTORS RELATED TO LIFETIME SUBSTANCE USE DISORDERS IN BEREAVED HIV-1+ AND HIV-1- HOMOSEXUAL MEN

    Article • Psychosomatic Medicine, January 1999, Wolters Kluwer Health

    Daniel Feaster

  293. Meta-analysis and the need for study quality control

    Article • Pain Forum, June 1998, Elsevier

    Daniel Feaster

  294. Meta-analysis: A time for closer scrutiny in applications to pain research?

    Article • Pain Forum, June 1998, Elsevier

    Daniel Feaster

  295. A Bereavement Support Group Intervention Is Longitudinally Associated with Salutary Effects on the CD4 Cell Count and Number of Physician Visits

    Article • Clinical and Diagnostic Laboratory Immunology, May 1998, ASM Journals

    Daniel Feaster

  296. Mild Cognitive Impairment and Risk of Mortality in HIV-1 Infection

    Article • Journal of Neuropsychiatry, May 1998, American Psychiatric Association

    Daniel Feaster

  297. Plasma Pyridoxine Deficiency Is Related to Increased Psychological Distress in Recently Bereaved Homosexual Men

    Article • Psychosomatic Medicine, January 1998, Wolters Kluwer Health

    Daniel Feaster

  298. Randomized Double-blind Placebo-Controlled Trial of Peptide T for HIV-Associated Cognitive Impairment

    Article • Archives of Neurology, January 1998, American Medical Association (AMA)

    Daniel Feaster

  299. ZINC DEFICIENCY IS RELATED TO DEPRESSED MOOD IN RECENTLY BEREAVED HOMOSEXUAL MEN

    Article • Psychosomatic Medicine, January 1998, Wolters Kluwer Health

    Daniel Feaster

  300. HIV-1 Proviral DNA Load Across Neuroanatomic Regions of Individuals With Evidence for HIV-1-Associated Dementia

    Article • Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology, November 1997, Wolters Kluwer Health

    Daniel Feaster

  301. A psychosocial model of distress over time in early hiv-1 infection: The role of life stressors, social support and coping

    Article • Psychology & Health, October 1997, Taylor & Francis

    Daniel Feaster

  302. A rapid method for comparative quantitative polymerase chain reaction of HIV-1 proviral DNA extracted from cryopreserved brain tissues

    Article • Journal of Virological Methods, September 1997, Elsevier

    Daniel Feaster

  303. Psychological Distress in HIV-1 Disease in Relationship to Hypocholesterolemia

    Article • The International Journal of Psychiatry in Medicine, June 1997, SAGE Publications

    Maria Jose Miguez, Daniel Feaster

  304. A Research Derived Bereavement Support Group Technique for the Hiv-1 Infected

    Article • OMEGA - Journal of Death and Dying, June 1997, SAGE Publications

    Daniel Feaster

  305. Bereavement and HIV infection

    Article • International Review of Psychiatry, January 1996, Taylor & Francis

    Daniel Feaster

  306. Bereavement is associated with time-dependent decrements in cellular immune function in asymptomatic human immunodeficiency virus type 1-seropositive homosexual men

    Article • Clinical and Diagnostic Laboratory Immunology, January 1996, ASM Journals

    Daniel Feaster

  307. Rebuttal

    Article • Pain Forum, December 1995, Elsevier

    Daniel Feaster

  308. On the putative efficacy of the antidepressants in chronic, benign pain syndromes

    Article • Pain Forum, December 1995, Elsevier

    Daniel Feaster

  309. Elevated IgE level in relationship to nutritional status and immune parameters in early human immunodeficiency virus–1 disease

    Article • Journal of Allergy and Clinical Immunology, April 1995, Elsevier

    Maria Jose Miguez, Daniel Feaster

  310. Impact of Vitamin B 6 Status on Psychological Distress in a Longitudinal Study of HIV-1 Infection

    Article • The International Journal of Psychiatry in Medicine, September 1994, SAGE Publications

    Daniel Feaster

  311. Active coping style is associated with natural killer cell cytotoxicity in asymptomatic HIV-1 seropositive homosexual men

    Article • Journal of Psychosomatic Research, October 1992, Elsevier

    Daniel Feaster

  312. Life Stressors and Coping Style are Associated with Immune Measures in HIV-1 Infection—A Preliminary Report

    Article • The International Journal of Psychiatry in Medicine, June 1992, SAGE Publications

    Daniel Feaster

  313. Cynical Hostility: A Risk Factor in HIV‐1 Infection?1

    Article • Journal of Applied Social Psychology, April 1991, Wiley

    Daniel Feaster

  314. A stress-moderator model of distress in early HIV-1 infection: Concurrent analysis of life events, hardiness and social support

    Article • Journal of Psychosomatic Research, January 1991, Elsevier

    Daniel Feaster

  315. A Selectivity Model of Employer-Size Wage Differentials

    Article • Journal of Labor Economics, January 1990, University of Chicago Press

    Daniel Feaster

  316. The Timing of Falls Into Poverty After Retirement and Widowhood

    Article • Demography, August 1988, Springer Science + Business Media

    Daniel Feaster

  317. Incidence, Timing, and Events Associated With Poverty: A Dynamic View of Poverty in Retirement

    Article • Journal of Gerontology, March 1988, Oxford University Press (OUP)

    Daniel Feaster

  318. Impact of 1981 AFDC Reforms on Months Worked and Welfare Duration

    Article • Journal of Human Resources, January 1987, JSTOR

    Daniel Feaster